UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

Phase 2

Completed

Conditions: Prostate Cancer
Anemia

Interventions: Drug: Aranesp

First Posted Date: 2005-10-28

Last Posted Date: 2007-11-29

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT00245895

Locations: 🇺🇸
Oregon Health and Sciences University, Portland, Oregon, United States
🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States

Evaluation of the Efficacy of the Becoming Parents Program

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Behavioral: Becoming Parents Program

First Posted Date: 2005-10-25

Last Posted Date: 2008-10-15

Lead Sponsor: University of Washington

Target Recruit Count: 940

Registration Number: NCT00243997

Rosiglitazone Effects on Cognition for Adults in Later Life

Phase 2

Conditions: Mild Cognitive Impairment

Interventions: Drug: Rosiglitazone

First Posted Date: 2005-10-20

Last Posted Date: 2011-08-05

Lead Sponsor: University of Washington

Target Recruit Count: 120

Registration Number: NCT00242593

Locations: 🇺🇸
UCLA Alzheimer's Disease Center, Los Angeles, California, United States
🇺🇸
University of Washington/VA Puget Sound Health Care System, Seattle/Tacoma, Washington, United States
🇺🇸
Banner Alzheimer Institute, Phoenix, Arizona, United States

Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event

Completed

Conditions: Rhabdomyolysis

First Posted Date: 2005-10-19

Last Posted Date: 2012-01-05

Lead Sponsor: University of Washington

Target Recruit Count: 187

Registration Number: NCT00241748

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer

Phase 1

Completed

Conditions: Esophageal Cancer

First Posted Date: 2005-10-13

Last Posted Date: 2013-05-17

Lead Sponsor: University of Washington

Target Recruit Count: 18

Registration Number: NCT00238147

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸
University of Washington School of Medicine, Seattle, Washington, United States

Managing Temporomandibular Disorder (TMD) Symptoms

Not Applicable

Completed

Conditions: Temporomandibular Joint Disorders

Interventions: Drug: 20 mcg ethinyl estradiol and 100 mcg levonorgestrel
Behavioral: Self Management
Behavioral: Targeted Self Management

First Posted Date: 2005-10-12

Last Posted Date: 2011-07-11

Lead Sponsor: University of Washington

Target Recruit Count: 252

Registration Number: NCT00237042

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Effects of ASA on Prostate Tissue

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Drug: Aspirin
Drug: Placebo

First Posted Date: 2005-10-06

Last Posted Date: 2016-05-25

Lead Sponsor: University of Washington

Target Recruit Count: 60

Registration Number: NCT00234299

Locations: 🇺🇸
VA Puget Sound Health Care Service, Seattle, Washington, United States

IC14 Antibodies to Treat Individuals With Acute Lung Injury

Phase 2

Terminated

Conditions: Respiratory Distress Syndrome, Adult
Lung Diseases

First Posted Date: 2005-10-05

Last Posted Date: 2017-05-16

Lead Sponsor: University of Washington

Target Recruit Count: 13

Registration Number: NCT00233207

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

Phase 4

Completed

Conditions: Hepatitis B

Interventions: Drug: Hepsera
Drug: Hepsera and lamivudine

First Posted Date: 2005-09-30

Last Posted Date: 2007-11-15

Lead Sponsor: University of Washington

Target Recruit Count: 19

Registration Number: NCT00230477

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Health Behavior Feedback Study for Veterans With Hepatitis C

Phase 1

Completed

Conditions: Alcoholism
Alcohol Abuse
Hepatitis C
Liver Disease

Interventions: Behavioral: 3 session brief intervention with health behavior feedback
Other: treatment as usual

First Posted Date: 2005-09-29

Last Posted Date: 2007-11-30

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT00229580

Locations: 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy